Overview
Praxis Precision Medicine is a clinical-stage biopharmaceutical company developing small molecule therapies targeting ion channel disorders of the brain, including epilepsy and essential tremor.
More in Neuropharmaceuticals
Latest industry news
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Tackle Neuroscience
2026-10-26 · Funding
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-10-25 · Product
Wearable Neurofeedback Startup BRYM Secures €650K to Build Next-Generation Brain Training Platform
2026-10-24 · Funding
Brain-Computer Interface Gives Unresponsive ICU Patients Auditory Control for the First Time
2026-10-23 · Research
Company details
Category
💊 Neuropharmaceuticals
Location
Cambridge, Massachusetts, USA
Funding
Publicly traded — NASDAQ: PRAX
Website
www.praxismedicines.comListed
2026-10-05
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →